Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Artículo en Inglés | WPRIM | ID: wpr-360637

RESUMEN

<p><b>OBJECTIVE</b>To investigate the association of estrogen receptor alpha (ER-alpha) PvuII polymorphisms with the effect of calcium supplementation on bone development in Chinese pubertal girls, and to study the importance of calcium supplementation by maximizing the peak bone mass at their pubertal stage for bone development and osteoporosis prevention and the role of estrogen in regulating bone mass.</p><p><b>METHODS</b>Ninety-four pubertal girls were recruited in the study and divided into two groups and three sub-groups according to the ER-alpha PvuII polymorphisms. One year before and after calcium supplementation, bone mineral density (BMD) was measured by DEXA, while BGP, BAP, TRACP5b, and 25-OH-VitD(3), as well as estrogen were detected by ELISA. Analysis of covariance was used to examine the effect of ER-alpha polymorphisms on bone development.</p><p><b>RESULTS</b>The absolute increase and percentage change of BGP were significantly higher in the supplemented group than in the control group (P<0.05). In the intervened group, The increase and percentage change of the total body and radio distal 1/3 BMD were higher in PP than in PP genotype (P<0.05), and the increase of BAP in Pp was also higher than PP in the same group (P<0.05).</p><p><b>CONCLUSION</b>PP genotype shows a better response to calcium supplementation than the other PvuII polymorphisms.</p>


Asunto(s)
Adolescente , Femenino , Humanos , Pueblo Asiatico , Biomarcadores , Densidad Ósea , Calcio , Farmacología , Suplementos Dietéticos , Receptor alfa de Estrógeno , Genética , Polimorfismo Genético , Pubertad , Fisiología
2.
Artículo en Chino | WPRIM | ID: wpr-352477

RESUMEN

<p><b>OBJECTIVE</b>To investigate the relationship between estrogen receptor gene Px haplotype and the effect of calcium and soy isoflavone supplementation on bone mineral density (BMD) of Chinese postmenopausal women.</p><p><b>METHODS</b>It was a randomly controlling test for 12 months. The Pvu II and Xba I polymorphisms of ER-alpha gene were detected by using restriction fragment length polymorphisms (RFLP) in 691 Chinese postmenopausal women, aged 45-65 years. In 497 carriers of definitive Pvu II-Xba I haplotype, 93 subjects were chosen randomly. BMD was measured by dual energy X-ray absorptiometry (DXEA). According to BMD T score in any skeleton site of 81 subjects at baseline, 29 subjects with T > or = -1.5 were grouped into observation group, and 52 subjects with T < -1.5 were randomly assigned into two intervention groups and received either a 100 mg soy isoflavone and 440 mg Ca and 100 IU VD supplement/d (n = 26) or 440 mg Ca and 100 IU VD supplement/d (n = 26). BMD of the whole body, lumber (L2-L4), and hip were measured at baseline and after 12 months.</p><p><b>RESULTS</b>After one year fellow-up, the BMD at L2-L4, femur neck site and whole body were significantly decreased as compared with those of baseline (P < 0.05, change percent of BMD as follows: -3.31%, -3.09%, -1.88%) in observation group, and the whole body BMD was significantly lower at 12 month than that at baseline in subjects with Px haplotype (percent change was -2.44%, P < 0.05), but no difference was found in subjects without Px haplotype. Whole body and femur neck BMD were significantly decreased in both Ca group and Ca + soy isoflavone group, but no significant difference of change percent between two groups. There were no significant changes in L2-L4 and trochanter BMD irrespective of treatment. ER-alpha Px haplotype had no effect on the changes in BMD in both Ca group and Ca + soy isoflavone group.</p><p><b>CONCLUSION</b>The rate of bone loss in Chinese postmenopausal women seems to haverelation to ER Px haplotype. Calcium supplementation for 1 year might lower the bone loss rate, but soy isoflavone supplementation for 1 year had notshowu no effects. The effect of supplementation had no relationship with ER Px haplotype.</p>


Asunto(s)
Anciano , Femenino , Humanos , Persona de Mediana Edad , Pueblo Asiatico , Genética , Densidad Ósea , Genética , Compuestos de Calcio , Farmacología , Suplementos Dietéticos , Receptor alfa de Estrógeno , Genética , Isoflavonas , Farmacología , Polimorfismo de Longitud del Fragmento de Restricción , Posmenopausia , Receptores de Estrógenos , Genética , Proteínas de Soja , Farmacología
3.
Artículo en Inglés | WPRIM | ID: wpr-249878

RESUMEN

<p><b>OBJECTIVE</b>NaFeEDTA was considered as a promising iron fortificant for controlling iron deficiency anemia. Soy sauce is a suitable food carrier for iron fortification and is a popular condiment in China. Iron absorption rates of NaFeEDTA and FeSO4 were observed and compared in adult female subjects.</p><p><b>METHODS</b>The stable isotope tracer method was used in Chinese females consuming a typical Chinese diet. Ten healthy young Chinese women were selected as subjects in the 15-day study. A plant-based diet was used based on the dietary pattern of adult women in the 1992 National Nutrition Survey. Six milligram of 54Fe in 54FeSO4 soy sauce and 3 mg 58Fe in Na58FeEDTA soy sauce were given to the same subjects in two days. Food samples and fecal samples were collected and analyzed.</p><p><b>RESULTS</b>Iron absorption rates of NaFeEDTA and FeSO4 were 10.51% +/- 2.83 and 4.73% +/- 2.15 respectively. The 58Fe (NaFeEDTA) absorption was significantly higher than that of 54Fe (FeSO4) (P < 0.01). The iron absorption rate from NaFeEDTA was 1.2 times higher than that from FeSO4 in Chinese adult women consuming a typical Chinese diet.</p><p><b>CONCLUSION</b>The higher absorption rate of NaFeEDTA suggested that NaFeEDTA would be a better iron fortificant used in soy sauce for the controlling of iron deficiency anemia in China.</p>


Asunto(s)
Adolescente , Adulto , Femenino , Humanos , China , Ácido Edético , Farmacocinética , Compuestos Férricos , Farmacocinética , Compuestos Ferrosos , Farmacocinética , Alimentos Fortificados , Hierro , Farmacocinética , Alimentos de Soja
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA